Stevanato Group S.p.A (STVN) Cost of Revenue (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Cost of Revenue came in at $232.3 million in Q1 2026, up 18.27% year-on-year from $196.4 million in Q1 2025, and down 16.72% on a QoQ basis from $278.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cost of Revenue (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cost of Revenue data on file, last reported at $232.3 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 18.27% year-over-year to $232.3 million in Q1 2026; TTM through Mar 2026 was $990.2 million, a 13.17% increase from a year earlier, with the FY2025 full-year figure at $980.6 million, up 14.46% from the prior year.
- Cost of Revenue for Q1 2026 stood at $232.3 million, down from $278.9 million in the prior quarter.
- Over the last five years, Cost of Revenue for STVN reached as high as $278.9 million in Q4 2025 and fell as low as $162.3 million in Q1 2022.
- Historically, Cost of Revenue has averaged $209.3 million across 5 years, with a median of $205.2 million in 2023.
- Across the five-year window, Cost of Revenue dropped 5.22% in 2022 and advanced 21.34% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $195.8 million in 2022, then rose by 20.24% to $235.4 million in 2023, then increased by 5.49% to $248.3 million in 2024, then increased by 12.31% to $278.9 million in 2025, then declined by 16.72% to $232.3 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $232.3 million in Q1 2026, $278.9 million in Q4 2025, and $251.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 2.56 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 18.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 5.51 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 532.58 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 11.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 303.50 Mn |
| 10 | Stevanato Group S.p.A | 5.39 Bn | 5.25 Bn | 88.01 Mn | 232.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 232.28 Mn |
| Mar 31, 2026 | 232.28 Mn |
| Dec 31, 2025 | 278.90 Mn |
| Dec 31, 2025 | 278.90 Mn |
| Sep 30, 2025 | 251.00 Mn |
| Sep 30, 2025 | 251.00 Mn |
| Jun 30, 2025 | 228.03 Mn |
| Jun 30, 2025 | 228.03 Mn |
| Mar 31, 2025 | 196.39 Mn |
| Mar 31, 2025 | 196.39 Mn |
| Dec 31, 2024 | 248.34 Mn |
| Dec 31, 2024 | 248.34 Mn |
| Sep 30, 2024 | 223.40 Mn |
| Sep 30, 2024 | 223.40 Mn |
| Jun 30, 2024 | 206.87 Mn |
| Jun 30, 2024 | 206.87 Mn |
| Mar 31, 2024 | 188.81 Mn |
| Mar 31, 2024 | 188.81 Mn |
| Dec 31, 2023 | 235.42 Mn |
| Dec 31, 2023 | 235.42 Mn |